全文获取类型
收费全文 | 13765篇 |
免费 | 659篇 |
国内免费 | 225篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 206篇 |
妇产科学 | 198篇 |
基础医学 | 2569篇 |
口腔科学 | 654篇 |
临床医学 | 1199篇 |
内科学 | 1631篇 |
皮肤病学 | 112篇 |
神经病学 | 1022篇 |
特种医学 | 182篇 |
外国民族医学 | 1篇 |
外科学 | 887篇 |
综合类 | 1375篇 |
现状与发展 | 2篇 |
一般理论 | 3篇 |
预防医学 | 1162篇 |
眼科学 | 153篇 |
药学 | 2281篇 |
16篇 | |
中国医学 | 421篇 |
肿瘤学 | 519篇 |
出版年
2023年 | 136篇 |
2022年 | 186篇 |
2021年 | 332篇 |
2020年 | 331篇 |
2019年 | 277篇 |
2018年 | 257篇 |
2017年 | 332篇 |
2016年 | 337篇 |
2015年 | 301篇 |
2014年 | 803篇 |
2013年 | 1129篇 |
2012年 | 1001篇 |
2011年 | 1229篇 |
2010年 | 916篇 |
2009年 | 1158篇 |
2008年 | 1125篇 |
2007年 | 654篇 |
2006年 | 603篇 |
2005年 | 587篇 |
2004年 | 483篇 |
2003年 | 428篇 |
2002年 | 285篇 |
2001年 | 185篇 |
2000年 | 161篇 |
1999年 | 159篇 |
1998年 | 201篇 |
1997年 | 194篇 |
1996年 | 109篇 |
1995年 | 116篇 |
1994年 | 104篇 |
1993年 | 74篇 |
1992年 | 45篇 |
1991年 | 53篇 |
1990年 | 50篇 |
1989年 | 28篇 |
1988年 | 34篇 |
1987年 | 16篇 |
1986年 | 17篇 |
1985年 | 29篇 |
1984年 | 30篇 |
1983年 | 27篇 |
1982年 | 23篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 18篇 |
1978年 | 9篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1974年 | 7篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Ashley V. Hill Natacha M. De Genna Maria J. Perez-Patron Tamika D. Gilreath Carmen Tekwe Brandie DePaoli Taylor 《The Journal of adolescent health》2019,64(3):319-326
Purpose
Syndemic theory suggests that the convergence of social, environmental, and ecological factors can interact to exacerbate behavioral health problems and are often intensified by social conditions and disparities. This study used latent class analysis (LCA) to determine gender and racial/ethnic specific classes for sexually transmitted infection (STI) risk.Methods
LCA included 18 measured socioeconomic, depression, substance use, and sexual behavioral variables from 1,664 young adults ages 18–25 in the NHANES. Models were stratified by gender and then by race/ethnicity. Logistic regression determined associations between latent class membership and testing positive for one or more STIs (Chlamydia trachomatis, HIV or herpes simplex virus-II). For each stratified analysis, classes with the lowest probability of reported risk factors in the LCA were the reference groups.Results
Class 3 in females (highest probability of reporting both socioeconomic and behavioral factors) and class 3 in males (majority behavioral factors) had increased odds of STI (females: OR?=?2.7, 95% CI 1.6–4.5; males: OR 2.5, 95% CI 1.3–4.6). By race for females, depression (highest in Hispanics), poverty, and less educated households (highest in blacks and Hispanics) were evident in classes associated with STI. Class 1 black males (majority behavioral factors) had a higher odds of STI compared with low risk white males (OR?=?16.4 95% CI 3.7–72.0) However, no other associations were observed among males.Conclusions
Risk patterns for STI differed by gender and race/ethnicity. Consistent with syndemic theory, effective STI interventions need to address socioeconomic factors and mental health rather than individual behaviors, particularly for minority women. 相似文献12.
13.
BackgroundAs an ongoing worldwide health issue, Coronavirus disease 2019 (COVID–19) has been causing serious complications, including pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. However, there is no decisive treatment approach available for this disorder, which is primarily attributed to the large amount of inflammatory cytokine production. We aimed to identify the effects of Nano-curcumin on the modulation of inflammatory cytokines in COVID-19 patients.MethodForty COVID-19 patients and 40 healthy controls were recruited and evaluated for inflammatory cytokine expression and secretion. Subsequently, COVID-19 patients were divided into two groups: 20 patients receiving Nano-curcumin and 20 patients as the placebo group. The mRNA expression and cytokine secretion levels of IL-1β, IL-6, TNF-α and IL‐18 were assessed by Real‐time PCR and ELISA, respectively.ResultOur primary results indicated that the mRNA expression and cytokine secretion of IL-1β, IL-6, TNF-α, and IL-18 were increased significantly in COVID-19 patients compared with healthy control group. After treatment with Nano-curcumin, a significant decrease in IL-6 expression and secretion in serum and in supernatant (P = 0.0003, 0.0038, and 0.0001, respectively) and IL-1β gene expression and secretion level in serum and supernatant (P = 0.0017, 0.0082, and 0.0041, respectively) was observed. However, IL-18 mRNA expression and TNF-α concentration were not influenced by Nano-curcumin.ConclusionNano-curcumin, as an anti-inflammatory herbal based agent, may be able to modulate the increased rate of inflammatory cytokines especially IL-1β and IL-6 mRNA expression and cytokine secretion in COVID-19 patients, which may cause an improvement in clinical manifestation and overall recovery. 相似文献
14.
目的:测定知母饮片炮制前后3个黄酮类和2个皂苷类成分变化。方法:采用高效液相色谱-紫外检测法(HPLC-UV)测定3个黄酮类成分,色谱柱为岛津Intetsil ODS-3(4.6 mm×250 mm,5μm),流动相为乙腈-0.2%冰醋酸,梯度洗脱,进样量20μL,流速1.0 mL/min,柱温30℃;采用高效液相色谱-蒸发光散射检测法(HPLC-ELSD)测定2个皂苷类成分,色谱柱为岛津Intetsil ODS-3(4.6 mm×250 mm,5μm),流动相为乙腈-0.2%冰醋酸,梯度洗脱,进样量10μL,流速1.0 mL/min,氮气流量2.5 mL/min,蒸发温度80℃。结果:知母饮片炮制后知母皂苷BⅡ、新芒果苷、芒果苷含量下降,知母皂苷AⅢ含量上升,异芒果苷含量相对稳定。结论:知母饮片炮制后部分知母皂苷BⅡ会转化成知母皂苷AⅢ,新芒果苷、芒果苷会转化成其他成分,异芒果苷结构相对稳定,不易转化成其他成分。 相似文献
15.
16.
Daniela S. Camilo Fernando Pradella Maria Fernanda Paulino Emilio C. E. Baracat Sofia H. Marini Gil Guerra Elizabeth J. Pavin Candida Parisi Ana Leda F. Longhini Silvia B. Marques Edilaine G. Guariento Sofia R. Lieber Carlos Fernando Macedo Letícia Gama e Silva Alessandro S. Farias Leonilda M. B. Santos Walkyria M. G. Volpini 《Pediatric diabetes》2020,21(4):606-614
17.
Lynette G. Sadleir Guillem de Valles-Ibáñez Chontelle King Matthew Coleman Stuart Mossman Sarah Paterson John Nguyen Samuel F. Berkovic Saul Mullen Melanie Bahlo Michael S. Hildebrand Heather C. Mefford Ingrid E. Scheffer 《Epilepsia》2020,61(4):e23-e29
Variants in RORB have been reported in eight individuals with epilepsy, with phenotypes ranging from eyelid myoclonia with absence epilepsy to developmental and epileptic encephalopathies. We identified novel RORB variants in 11 affected individuals from four families. One was from whole genome sequencing and three were from RORB screening of three epilepsy cohorts: developmental and epileptic encephalopathies (n = 1021), overlap of generalized and occipital epilepsy (n = 84), and photosensitivity (n = 123). Following interviews and review of medical records, individuals' seizure and epilepsy syndromes were classified. Three novel missense variants and one exon 3 deletion were predicted to be pathogenic by in silico tools, not found in population databases, and located in key evolutionary conserved domains. Median age at seizure onset was 3.5 years (0.5-10 years). Generalized, predominantly absence and myoclonic, and occipital seizures were seen in all families, often within the same individual (6/11). All individuals with epilepsy were photosensitive, and seven of 11 had cognitive abnormalities. Electroencephalograms showed generalized spike and wave and/or polyspike and wave. Here we show a striking RORB phenotype of overlap of photosensitive generalized and occipital epilepsy in both individuals and families. This is the first report of a gene associated with this overlap of epilepsy syndromes. 相似文献
18.
《Clinical microbiology and infection》2020,26(1):87-94
ObjectivesThe aim of the study was to measure the impact of antibiotic exposure on the acquisition of colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria (ESBL-GNB) accounting for individual- and group-level confounding using machine-learning methods.MethodsPatients hospitalized between September 2010 and June 2013 at six medical and six surgical wards in Italy, Serbia and Romania were screened for ESBL-GNB at hospital admission, discharge, antibiotic start, and after 3, 7, 15 and 30 days. Primary outcomes were the incidence rate and predictive factors of new ESBL-GNB colonization. Random forest algorithm was used to rank antibiotics according to the risk of selection of ESBL-GNB colonization in patients not colonized before starting antibiotics.ResultsWe screened 10 034 patients collecting 28 322 rectal swab samples. New ESBL-GNB colonization incidence with and without antibiotic treatment was 22/1000 and 9/1000 exposure-days, respectively. In the adjusted regression analyses, antibiotic exposure (hazard ratio (HR) 2.38; 95% CI 1.29–4.40), age 60–69 years (HR 1.19; 95% CI 1.05–1.34), and spring season (HR 1.25; 95% CI 1.14–1.38) were independently associated with new colonization. Monotherapy ranked higher als combination therapy in promoting ESBL-GNB colonization. Among monotherapy, cephalosporins ranked first followed by tetracycline (second), macrolide (fourth) and cotrimoxazole (seventh). Overall the ranking of cephalosporins was lower when used in combination. Among combinations not including cephalosporins, quinolones plus carbapenems ranked highest (eighth). Among sequential therapies, quinolones ranked highest (tenth) when prescribed within 30 days of therapy with cephalosporins.ConclusionsImpact of antibiotics on selecting ESBL-GNB at intestinal level varies if used in monotherapy or combination and according to previous antibiotic exposure. These finding should be explored in future clinical trials on antibiotic stewardship interventions.Clinical Trial registrationNCT01208519. 相似文献
19.
《Clinical microbiology and infection》2020,26(4):456-462
ObjectivesInfections with extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (EPE) are a major healthcare concern. Our goal was to investigate whether a probiotic mixture could be used for eradication therapy in patients with prolonged intestinal EPE carriage.MethodsWe performed a randomized, placebo-controlled, single-blinded clinical superiority trial in the south of Sweden between February 2017 and April 2019. Probiotic Vivomixx®, a mixture of 8 different living bacterial strains or placebo was given to adult outpatients intestinally colonized for at least 3 months with EPE. Patients with suspected active infections at the time of evaluation were excluded, and also those with immunosuppression, severe psychiatric disorder, drug abuse or dementia. Each patient in the probiotic arm was administered 2 sachets (9.0 × 1011 live bacteria) twice daily for 2 months. The primary outcome was intestinal EPE eradication at the end of the 1-year follow-up, as shown by 3 consecutive negative EPE rectal swabs during the follow-up year. The per protocol follow-up for all patients was 1, 3, 6 and 12 months after the initiation of the intervention. ClinicalTrials.gov Identifier: NCT03860415.ResultsIn total, the target size of 80 patients were included. The median age was 68 years in both groups. The number of females in the probiotics group was 23 (58%) and in the placebo group 28 (70%). At the end of the trial, 12.5% (5 out of 40) of the patients in the probiotic group had achieved successful eradication of EPE, as defined by the primary outcome, in the intention to treat analysis. In the placebo group, 5% (2 out of 40) of the patients had achieved successful eradication of EPE (odds ratio 2.71; 95% confidence interval (CI), 0.49–14.9; p 0.24).ConclusionsSuccessful EPE eradication was observed in very few individuals. This trial did not support Vivomixx® as being superior to placebo for intestinal decolonization in adult patients with chronic colonization of EPE, but was limited in power. 相似文献
20.
《Clinical microbiology and infection》2020,26(8):1046-1051
ObjectivesInfections as a result of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) are considered infections with a high public health burden. In this study, we aimed to identify incidences of and risk factors for healthcare-associated infections (HAIs) after rectal colonization with ESBL-producing Escherichia coli (ESBL-EC) or Klebsiella pneumoniae (ESBL-KP).MethodsThis prospective cohort study was performed in 2014 and 2015. Patients colonized with ESBL-EC or ESBL-KP were monitored for subsequent HAI with ESBL-E and other pathogens. In the case of an ESBL-E infection, rectal and clinical isolates were compared using pulsed-field gel electrophoresis (PFGE), and whole-genome sequencing (WGS) for ESBL-KP isolates. Proportional hazard models were applied to identify risk factors for HAIs, and to analyse competing risks.ResultsAmong all patients admitted to the hospital during the study period, 13.6% were rectally screened for third-generation cephalosporin-resistant Enterobacterales (3GCREB). A total of 2386 rectal carriers of ESBL-EC and 585 of ESBL-KP were included in the study. Incidence density (ID) for HAI with ESBL-E was 2.74 per 1000 patient days at risk (95% confidence interval (CI) 2.16–3.43) among carriers of ESBL-EC, while it was 4.44 per 1000 patient days at risk (95% CI 3.17–6.04) among carriers of ESBL-KP. In contrast, ID for HAI with other pathogens was 4.36 per 1000 patient days at risk (95% CI 3.62–5.21) among carriers of ESBL-EC, and 5.00 per 1000 patient days at risk (95% CI 3.64–6.69) among carriers of ESBL-KP. Cox proportional hazard regression analyses identified colonization with ESBL-KP (HR = 1.58, 95% CI 1.068–2.325) compared with ESBL-EC as independent risk factor for HAI with ESBL-E. The results were consistent over all competing risk analyses.ConclusionsClinicians should be aware of the increased risk of ESBL-E infections among patients colonized with ESBL-KP compared with ESBL-EC that might be caused by underlying diseases, higher pathogenicity of ESBL-KP and other factors. 相似文献